Modern Chemotherapy Flashcards

1
Q

What is a Nib?

A

Tyrosine Kinase inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is a Rib (THINK R)?

A

PARP inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What does PARP stand for?

A

Poly(ADP)ribose Polymerase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Name a PARP inhibitor.

A

Olaparib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Name a Tyrosine Kinase inhibitor.

A

Imatinib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What does PARP do?

A

It fixes single strand breaks in DNA (e.g. those caused by Topoisomerase I).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What genes do PARP inhibitors target?

A

BRCA 1 & 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What do healthy BRCA 1 & 2 genes do?

A

They produce proteins that are involved in the repair of double strand breaks in DNA.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What happens if PARP is inhibited?

A

The single strand breaks in DNA cannot be repaired. This damage is carried forward through proliferation and leads to double strand breaks. These can either be repaired by homologous recombination or apoptosis occurs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How does Olaparib work?

A

It is a competitive inhibitor of NAD+ and the BER pathway. This inhibition causes an accumulation of single strand breaks, which leads to a further accumulation of double strand breaks. BRCA that is faulty cannot repair these breaks and therefore the tumour cells become genomically unstable and undergo cell death.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What influenced Olaparib development?

A

The cyclopropylamide group in Olaparib increased its oral bioavailability. Its metabolic conversion into a piperazine increased both cell permeability and potency.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What does CML stand for?

A

Chronic myelogenous leukaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Name a BRAF inhibitor.

A

Sorafenib, Vemurafenib, Dabrafenib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How might resistance arise to Tyrosine Kinase inhibitors?

A

Upregulation of other growth related tyrosine kinases, or site mutations in the binding site of the target kinase.

For example, a T790M mutation at an EGFR receptor in Lung Cancer can reactivate the pathway which prevents TKI binding.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How was Imatinib developed?

A

It was developed from a lead molecule (2-phenylaminopyrimidines) with low potency and low selectivity as a kinase inhibitor. Addition of p-methyl group on aromatic ring introduced ABL kinase activity. Introduction of piperazine offered water solubility.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How do B-Raf inhibitors work?

A

Many melanomas have mutations in the B-Raf protein (amino acid V600E). This mutation allows for downstream signalling without ligand binding and activation. B-Raf inhibitors bind to the ATP pocket and prevent phosphorylation.